Brian Wilson Articles
Last 50 articles...
- Why Investors Continue to Flee Aegerion Stock
- Ariad Stock's Biggest Risk Is Its Only Hope
- Up 33%: Is Vertex Pharmaceuticals Stock Overpriced?
- Is This the Crown Jewel of the ISIS Pipeline?
- Why Teva's Magic Bullet Could Misfire
- Why I'm Still Avoiding Questcor
- Will Amgen’s Acquisition of Onyx Pay off Soon?
- Pharma’s Huge Bet on Immunotherapies
- Bristol-Myers Squibb's Oncology Opportunity
- Exceptional Growth in the Research Supply Industry
- Why This "Worst Deal" Could Work